FDA Floats Broader Pathway For Nicotine Replacement Therapies

FDA’s report to Congress on tobacco abstinence therapy points toward a “comprehensive strategy” for tobacco and nicotine product regulation, incorporating the work of the drug, device and tobacco centers. Some smoking cessation experts say changes are overdue.

More from United States

More from North America